Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-20

FDA Approved: GEMCITABINE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approves Sagent Pharmaceuticals' original ANDA for gemcitabine, a generic injectable chemotherapy used to treat several cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)

Snippet

ORIG AP for GEMCITABINE (GEMCITABINE)